Successful Use of Pembrolizumab to Treat Refractory Thymic Carcinoma with High PD-L1 Expression

Successful Use of Pembrolizumab to Treat Refractory Thymic Carcinoma with High PD-L1 Expression

Thymic carcinoma is a relatively rare and aggressive thymic epithelial tumor. Herein, we report successful treatment of thymic carcinoma with pembrolizumab. A 68-year-old woman was admitted to our hospital for evaluation of chest pain. Chest computed tomography showed a mass in the anterior mediasti...

Full description

Bibliographic Details
Main Authors: Takuma Isshiki, Kazutoshi Isobe, Naobumi Tochigi, Motoko Sunakawa, Yasuhiko Nakamura, Kazutoshi Shibuya, Susumu Sakamoto, Yujiro Takai, Sakae Homma
Format: Article
Language:English
Published: Karger Publishers 2018-10-01
Series:Case Reports in Oncology
Subjects:
Pembrolizumab
PD-1
PD-L1
Thymic carcinoma
Online Access:https://www.karger.com/Article/FullText/493187

Internet

https://www.karger.com/Article/FullText/493187

Similar Items